The fight against cancer is constant, and early detection is essential. Traditional biopsy procedures are effective for early detection, but can be invasive and carry risks. Fortunately, the liquid biopsy offers a potentially simpler and less intrusive approach to its counterpart. Voler Systems , a well-known company specializing in complex medical device design , collaborated with Guangzhou EZLife BioSci Tech Co. Ltd. on a ground breaking project. This project involved developing a liquid biopsy platform for early lung cancer detection. The innovative platform uses a medical instrument developed to analyze minuscule electrical currents within a blood sample. The Challenge - Taking Accurate Measurements in a Noisy Environment The challenge facing this China-based company was the complexity of the instrument. It requires extreme precision to accurately measure electrical currents (from 10 picoamps to 50 microamps) within a blood sample. In addition, the external noise stood...